---
title: "ECDC: European hospital infections from superbug Klebsiella pneumoniae up by 72%"
description: "The ECDC reports a 72% increase in hospital-acquired infections caused by resistant Klebsiella pneumoniae in the EU between 2019 and 2025. Mortality reaches 70%, and some strains are resistant even to new antibiotics."
date: 2026-11-18T17:37:31.569Z
lang: en
url: https://xab.info/en/posts/ecdc-europe-hospital-infections-klebsiella-pneumoniae-72-percent
tags: [klebsiella-pneumoniae, antimicrobial-resistance, ecdc, hospital-infections, europe-health]
author: "Darya Fomina"
publisher: "XAB.info"
---

# ECDC: European hospital infections from superbug Klebsiella pneumoniae up by 72%

![A healthcare worker in full PPE hugs an elderly patient in a hospital ward](https://xab.info/media/2026/11/18/ecdc-v-bolnitsah-evropyi-72-rost-infekciy-klebsiella-pneumoniae/ecdc-v-bolnitsah-evropyi-72-rost-infekciy-klebsiella-pneumoniae-1.webp)

## Key Points

- From 2019 to 2025, the number of bloodstream infections caused by resistant Klebsiella pneumoniae in the EU rose by 72%, according to the ECDC.
- Mortality from these infections is 40–70%, with some strains resistant to almost all antibiotics, including new ones.
- Approximately 35,000 people die annually in the EU, Iceland, and Norway due to antimicrobial-resistant infections.
- ECDC calls for better hand hygiene, PPE use, and disinfection; efforts against MRSA (-19% by 2025) may not work for Klebsiella due to gut reservoirs.

The European Centre for Disease Prevention and Control (ECDC) has recorded a worrying trend in healthcare-associated infections caused by the bacterium *Klebsiella pneumoniae*. According to the centre's latest reports, from 2019 to 2025, the number of bloodstream infections caused by resistant strains of this bacterium increased by 72%. This means that the EU's goal of reducing such cases by 5% by 2030 is effectively moving further out of reach, with the real trend moving in the opposite direction.

### Mortality up to 70% and resistance to new drugs

Infections related to *Klebsiella pneumoniae* pose a particular threat to hospitalized patients. Estimates suggest that the mortality rate for such diseases ranges from 40% to 70%. Laboratory analyses show that certain strains of the bacterium have developed resistance to almost all known antibiotics, including the newest treatments. Christian Giske, head of the ECDC research department, called the situation with resistant *Klebsiella pneumoniae* the most alarming of all superbug data collected in Europe over the past year.

### Part of a wider antimicrobial resistance problem

The increase in cases is only the visible part of a broader phenomenon: antimicrobial resistance, the ability of bacteria and fungi to adapt to the drugs intended to destroy them. It is estimated that about 35,000 people die each year due to such infections in the EU, Iceland, and Norway. Giske characterizes this as a serious threat to public health, emphasizing that the problem affects not just individual hospitals, but the entire regional healthcare system.

### Call for intensified infection control

Since the bacterium can be transmitted from patient to patient, the ECDC is calling on hospitals to strengthen infection prevention and control. Necessary measures include meticulous hand hygiene, correct use of gloves and other personal protective equipment, as well as thorough cleaning and disinfection of facilities. Such approaches have already proven effective in combating another dangerous hospital bacterium, MRSA: in 2025, the number of bloodstream infections caused by it was 19% lower than in 2019, exceeding the EU target of a 15% reduction by 2030.

### Why Klebsiella is harder to manage than MRSA

However, according to Giske, the situation with Klebsiella is more complex. The bacterium resides in the human gut and can form significant reservoirs there, meaning measures that were effective against MRSA will not necessarily produce a comparable result in the fight against *Klebsiella pneumoniae*. To contain its spread, hospitals will have to adhere to even stricter infection safety rules than those applied previously.

### Context: other outbreaks in Europe

The superbug situation fits into the broader context of infectious threats in the region. Recall that in May 2026, an outbreak of the Andes hantavirus strain occurred on the Dutch cruise ship MV Hondius, leading to several deaths. Five Ukrainian citizens were on board the vessel — no symptoms of the disease were detected in them. Both episodes highlight that Europe's healthcare system is facing simultaneous pressure from several persistent and highly lethal pathogens.

## Fact-Check & Sources

- [В больницах Европы распространяется опасная супербактерия, смертность достигает 70%](https://www.rbc.ua/ukr/news/likarnyah-evropi-poshiryuetsya-nebezpechna-1794998832.html) - Source: ECDC data on 72% growth (2019–2025), mortality 40–70%, Christian Giske quotes, 35k deaths per year, comparison with MRSA (-19%), MV Hondius context (May 2026).
- [Politico: опасная "супербактерия" распространяется в больницах Европы](https://www.m24.ru/news/18112026/965999) - Подтверждает рост случаев заражения устойчивыми штаммами Klebsiella pneumoniae на 72% с 2019 по 2025 год со ссылкой на Politico/ECDC.
- [Politico: в европейских больницах распространяется опасная «супербактерия»](https://news.rambler.ru/world/57437391-politico-v-evropeyskih-bolnitsah-rasprostranyaetsya-opasnaya-superbakteriya/) - Подтверждает 72%-й рост, устойчивость к новым антибиотикам, смертность 40–70%, необходимость СИЗ и дезинфекции.
- [Европу захватывает супербактерия, которая не лечится никакими антибиотиками: смертность ...](https://63.ru/text/health/2026/11/18/76774344/) - Подтверждает данные ECDC о росте заражений на 72% (2019–2025) и устойчивости штаммов.

## FAQ

### By how much have infections from Klebsiella pneumoniae increased in Europe?

According to the ECDC, the number of bloodstream infections caused by resistant Klebsiella pneumoniae increased by 72% between 2019 and 2025.

### What is the mortality rate for these infections?

The mortality rate typically ranges from 40% to 70%.

### Why is this bacterium harder to control than MRSA?

Klebsiella pneumoniae lives in the human gut and forms significant reservoirs, making measures effective against MRSA less effective for this bacterium.

### What measures does the ECDC recommend?

Meticulous hand hygiene, proper use of gloves and other PPE, and thorough cleaning and disinfection of premises.